| Kasie Iodice, PSY D | |
|
2000 Massachusetts Ave Ste 4, Cambridge, MA 02140-2100 | |
| (781) 430-8381 | |
| Not Available |
| Full Name | Kasie Iodice |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2000 Massachusetts Ave Ste 4, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033662143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
| 103TC0700X | Psychologist - Clinical | 11432 (Massachusetts) | Primary |
| Entity Name | Youth Opportunities Upheld Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245317205 PECOS PAC ID: 9638190374 Enrollment ID: O20051209000469 |
News Archive
A new drug regimen is reported to have marked benefits in treating the troublesome and distressing skin condition called eczema. The study, published in February 2020 in the journal Science Translational Medicine, shows that boosting the levels of a type of immune cell called natural killer cells can be a more effective way to treat eczema in a mouse study.
Robert Reinhart calls the medial frontal cortex the "alarm bell of the brain." "If you make an error, this brain area fires," says Reinhart, an assistant professor of psychological and brain sciences at Boston University. "If I tell you that you make an error, it also fires.
The United States is the only industrialized nation that doesn't guarantee access to health care for all its citizens. ... That's what Obamacare is designed to fix. ... That's why the next president – whether it is Barack Obama or Mitt Romney -; should defend Obamacare and make sure it's fully implemented. Despite what he's said on the campaign trail, Gov. Romney knows this is the responsible thing to do because of what has happened in Massachusetts since the passage of "Romneycare."
Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kasie Iodice, PSY D 2000 Massachusetts Ave Ste 4, Cambridge, MA 02140-2100 Ph: (781) 430-8381 | Kasie Iodice, PSY D 2000 Massachusetts Ave Ste 4, Cambridge, MA 02140-2100 Ph: (781) 430-8381 |
News Archive
A new drug regimen is reported to have marked benefits in treating the troublesome and distressing skin condition called eczema. The study, published in February 2020 in the journal Science Translational Medicine, shows that boosting the levels of a type of immune cell called natural killer cells can be a more effective way to treat eczema in a mouse study.
Robert Reinhart calls the medial frontal cortex the "alarm bell of the brain." "If you make an error, this brain area fires," says Reinhart, an assistant professor of psychological and brain sciences at Boston University. "If I tell you that you make an error, it also fires.
The United States is the only industrialized nation that doesn't guarantee access to health care for all its citizens. ... That's what Obamacare is designed to fix. ... That's why the next president – whether it is Barack Obama or Mitt Romney -; should defend Obamacare and make sure it's fully implemented. Despite what he's said on the campaign trail, Gov. Romney knows this is the responsible thing to do because of what has happened in Massachusetts since the passage of "Romneycare."
Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.
› Verified 4 days ago